Wie hoch ist der Preis für OmniAb, Inc. (OABI)

Preis für OmniAb, Inc. (OABI) ist $4.48

Wie hoch ist die Marktkapitalisierung für OmniAb, Inc. (OABI)

Marktkapitalisierung für OmniAb, Inc. (OABI) ist $649.33M

OmniAb, Inc. (OABI) Kursverlauf

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.

Jahr	Leistung
2026 (TTM)	1.00%
2025	-47.69%
2024	-30.70%
2023	49.25%
2022	-63.59%
2021	0.00%

Jahr

Leistung

2026 (TTM)

1.00%

2025

-47.69%

2024

-30.70%

2023

49.25%

2022

-63.59%

2021

0.00%

Unternehmen	Aktienkurs	Veränderung 1J%	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$542.09	38.63%	US
Argenx SE ARGX.US	$1.03K	44.13%	NL
CSL Limited CSL.AX	$121.53	-12.70%	AU
Moderna, Inc. MRNA.US	$138.18	473.58%	US
Lonza Group AG LONN.SW	$759.27	7.20%	CH

Unternehmen

Aktienkurs

Veränderung 1J%

Land